USD/CHF has maintained its rejection from 0.9372/55. A sustained close below here remains needed to confirm weakness over the next month, according to economists at Credit Suisse.
200DMA at 0.9629 ideally holds any further upside
“USD/CHF has extended its rejection of the key support zone at 0.9372/55. Whilst this development stays in line with improving near-term momentum and we see scope to extend this recovery for now, our broader bias remains negative, and we continue to look for an eventual turn back lower.”
“Immediate support is found at 0.9500/9496 and then at 0.9475/71, though a stable close below the major support zone at 0.9372/55 remains seen as needed to confirm weakness over the next month and open the door to 0.9322/12.”
“A close above the 200-day average at 0.9629 would raise a question mark over our broader bearish bias, with next resistance above here then seen at 0.9683/9700.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.